About Us
Kanchan Healthcare Inc., USA, is powered by a team with 150 years of combined expertise in manufacturing, operations, logistics, distribution, business development, R&D, regulatory affairs, project management, and quality assurance.
Kanchan Healthcare Inc., USA, has strengthened its presence in Latin America, Southeast Asia, and the GCC regions. In 2024, the company entered the US market by acquiring six Abbreviated New Drug Applications (ANDAs), expanding its international portfolio and opening new opportunities in the US pharmaceutical market.
We offer a diverse product portfolio of niche, specialized, and non-infringing products at various stages. Our team is focused on launching these products and exploring global opportunities. We have exclusive partnerships with cGMP-compliant CMOs approved by the US FDA, EMA, Health Canada, and TGA.
Our Vision
To be a globally recognized pharmaceutical company known for its commitment to quality, innovation, and patient-centric healthcare solutions, while continuously expanding access to affordable and effective medicines.
Our vision is to be a globally trusted leader in the pharmaceutical industry, leveraging our expertise in highly regulated markets to deliver excellence in warehousing, distribution, and supply chain management while maintaining the highest standards of compliance and quality.
Our Mission
- To develop, manufacture, and distribute high-quality pharmaceutical products that meet global healthcare needs.
- To ensure affordable access to medicines for patients across global markets.
- To foster strategic collaborations with research institutions, regulatory bodies, and global partners.
- To uphold the highest standards of quality, safety, and compliance in every aspect of our operations.
- To drive innovation in drug development through advanced R&D, ensuring effective treatment options.
Meet Our Leadership Team
Mr. Rakesh Bhikhalal Shah
Chairman
A second-generation entrepreneur based in Ahmedabad, Mr. Rakesh Bhikhalal Shah has made remarkable contributions to the pharmaceutical distribution industry. Building on a 35-year family legacy, he has established a pan-India presence with Kanchan Pharma Pvt. Ltd, which specializes in end-to-end supply chain management and marketing of ethical medicines. He is also a Founder Investor of Eris Life Sciences Limited.
Dr. S. Vishweshwar
Managing Partner
Dr. S. Vishweshwar, a pharmacist by education and profession, brings over 22 years of hands-on experience in technical, plant auditing, and regulatory consulting. As a Principal Consultant, he has specialized expertise in cGMP audits, regulatory filings, and quality assurance, with extensive knowledge in handling CAPA and post-submission regulatory queries for a wide range of API and finished products.
Dev Kumar Singh
CEO / Partner
With 30 years of experience in the international pharmaceutical formulations sector, Dev Kumar Singh is a dynamic leader with a proven track record in business development, marketing, and general management. His leadership has been instrumental in navigating multicultural teams and overseeing complex projects, making him a vital force in the company’s strategic growth.
Jeffrey Weiss
President, Sales and Marketing / Partner
With over 35 years of experience in the generic drug industry, Jeffrey Weiss has held senior leadership roles in multinational organizations. He specializes in crafting and executing growth strategies for early-stage and mid-tier generic companies, helping to steer commercial and general management to new heights.
Business Operations
Corporate Headquarters
The U.S. headquarters oversees global operations, providing strategic direction and coordination to ensure alignment with the company’s vision and goals.
Global Presence
The company has offices in India, Turkey, Jordan, Algeria, and Kenya, Vietnam, Dubai and Columbia ensuring a strong local presence. These offices build relationships with stakeholders, aid market entry, and adapt strategies to meet local demands.
Robust Presence
The company’s strong presence in the LATAM and CIS regions highlights its commitment to global expansion, focusing on sales, marketing, and distribution to drive growth and secure a competitive edge in expanding markets.
Ongoing and Expanding Business Operations
The company’s active business engagements in Colombia, Peru, Mexico, Turkey, UAE, KSA, Jordan, the Philippines, Poland, and Vietnam highlight its extensive global presence.
